Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in Laminin α2 Chain-deficient muscle

Molecular and Cellular Proteomics

Volumn 13, Issue 11, 2014, Pages 3001-3013

  De Oliveira, Bruno Menezes ^a   Matsumura, Cintia Y ^a,b   Fontes Oliveira, Cibely C ^a   Gawlik, Kinga I ^a   Acosta, Helena ^c   Wernhoff, Patrik ^a   Durbeej, Madeleine ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ACONITATE HYDRATASE; ADENYLATE KINASE; ADENYLOSUCCINATE SYNTHASE; ALPHA ACTININ 3; ALPHA TROPOMYOSIN; ASPARTATE AMINOTRANSFERASE ISOENZYME 2; CITRATE SYNTHASE; CREATINE KINASE; CYTOCHROME C OXIDASE; ELONGATION FACTOR 1ALPHA; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN PHOSPHORYLASE; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; LAMININ ALPHA2; LIM PROTEIN; MYOSIN; MYOSIN BINDING PROTEIN C; PARVALBUMIN; PHOSPHATE TRANSPORTER; PHOSPHOGLUCOMUTASE; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRIOSEPHOSPHATE ISOMERASE; TROPONIN C; TROPONIN I; UNINDEXED DRUG; CALCIUM; LAMININ; SCLEROPROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DIAPHRAGM MUSCLE; EXTRACELLULAR MATRIX; GASTROCNEMIUS MUSCLE; GENE EXPRESSION PROFILING; LIQUID CHROMATOGRAPHY; MOUSE; MUSCLE FIBER MEMBRANE; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEOMICS; QUANTITATIVE ANALYSIS; SARCOPLASMIC RETICULUM; TANDEM MASS SPECTROMETRY; UPREGULATION; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BIOSYNTHESIS; DEFICIENCY; DIAPHRAGM; DISEASE MODEL; FIBROSIS; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

ANIMALS; CALCIUM; DIAPHRAGM; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; LAMININ; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; TANDEM MASS SPECTROMETRY;

EID: 84910684594     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.032276     Document Type: Article

References (69)

1. Allamand, V., and Guicheney, P. (2002) Merosin-deficient muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for -2 chain of laminin). Eur. J. Hum. Genet. 10, 91-94
2. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tomé, F. M. S., Schwartz, K., Fardeau, M., Tryggvason, K., and Guicheney, P. (1995) Mutations in the laminin -2 chain gene (LAMA2) cause merosin-deficient muscular dystrophy. Nat. Genet. 11, 216-218
3. Voit, T., and Tomé, F. S. (2004) The congenital muscular dystrophies. In Myology (Angel, A., and Franzini-Armstrong, C., eds) Vol. 2, pp. 1203-1238, McGraw-Hill, New York
4. Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., and Campbell, K. P. (1992) Primary structure of dystrophin-Associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702
5. Talts, J. F., Andac, Z., Gohring, W., Brancaccio, A., and Timpl, R. (1999) Binding of the G domains of laminin -1 and -2 chains and perlecan to heparin, sulfatides, -dystroglycan and several extracellular matrix proteins. EMBO J. 18, 863-870
6. von der Mark, H., Williams, I., Wendler, O., Sorokin, L., von der Mark, K., and Pöschl, E. (2002) Alternative splice variants of -7-1 integrin selectively recognize different laminin isoforms. J. Biol. Chem. 277, 6012-6016
7. Gawlik, K. I., and Durbeej, M. (2011) Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet. Muscle 1, 9
8. Han, R., Kanagawa, M., Yoshida-Moriguchi, T., Rader, E. P., Ng, R. A., Michele, D. E., Muirhead, D. E., Kunz, S., Moore, S. A., Iannaccone, S. T., Miyake, K., McNeil, P. L., Mayer, U., Oldstone, M. B. A., Faulkner, J. A., and Campbell, K. P. (2009) Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of -dystroglycan. Proc. Natl. Acad. Sci. U.S.A. 106, 12573-12579
9. Vachon, P. H., Xu, H., Liu, L., Loechel, F., Hayashi, Y., Arahata, K., Reed, J. C., Wewer, U. M., and Engvall, E. (1997) Integrins (-7-1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 10, 1870-1881
10. Mayer, U. (2003) Integrins: redundant or important players in skeletal muscle and beyond. J. Biol. Chem. 279, 14587-14590
11. Gawlik, K. I., Mayer, U., Blomberg, K., Sonnenberg, A., Ekblom, P., and Durbeej, M. (2006) Laminin -1 chain mediated reduction of laminin -2 chain deficient muscular dystrophy involves integrin -7-1 and dystroglycan. FEBS Lett. 580, 1759-1765
12. Moll, J., Barzaghi, P., Lin, S., Bezakova, G., Lochmuller, H., Engvall, E., Muller, U., and Ruegg, M. A. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 413, 302-307
13. Doran, P., Martin, G., Dowling, P., Jockusch, H., and Ohlendieck, K. (2006) Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6, 4610-4621
14. Gardan-Salmon, D., Dixon, J. M., Lonergan, S. M., and Selsby, J. T. (2011) Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. Eur. J. Appl. Physiol. 111, 2763-2773
15. Carberry, S., Zweyer, M., Swandulla, D., and Ohlendieck, K. (2012) Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy. Int. J. Mol. Med. 30, 229-234
16. Ge, Y., Molloy, M. P., Chamberlain, J. S., and Andrews, P. C. (2003) Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3, 1895-1903
17. Guevel, L., Lavoie, J. R., Perez-Iratxeta, C., Rouger, K., Dubreil, L., Feron, M., Talon, S., Brand, M., and Megeney, L. A. (2010) Quantitative proteomic analysis of dystrophic dog muscle. J. Proteome Res. 10, 2465-2449
18. Matsumura, C. Y., Menezes de Oliveira, B., Durbeej, M., and Marques, M. J. (2013) Isobaric tagging-based quantification for proteomic analysis: a comparative study of spared and affected muscles from mdx mice at the early phase of dystrophy. PLoS One 8, e65831
19. Rayavarapu, S., Coley, W., Cakir, E., Jahnke, V., Takeda, S., Aoki, Y., Grodish-Dressman, H., Jaiswal, J. K., Hoffman, E. P., Brown, K. J., Hathout, Y., and Nagaraju, K. (2013) Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol. Cell. Proteomics 12, 1061-1073
20. Lewis, C., Carverry, S., and Ohlendieck, K. (2009) Proteomic profiling of x-linked muscular dystrophy. J. Muscle Res. Cell. Motil. 30, 267-279
21. De la Torre, C., Illa, I., Faulkner, G., Soria, L., Robles-Cedeno, R., Pereles-Dominguez-Perles, R., De Luna, N., and Gallardo, E. (2009) Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients. Proteomics Clin. Appl. 3, 486-497
22. de Morrée, A., Hensbergen, P. J., van Haagen, H. H., Dragan, I., Deelder, A. M., 't Hoen, P. A., Frants, R. R., and van der Maarel, S. M. (2010) Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity. PLoS One 5, e13854
23. Washburn, M., Wolters, D., and Yates, J., III (2001) Large scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247
24. Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., Johnstone, R., Mohammed, A. K., and Hamon, C. (2003) Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895-904
25. Carmignac, V., Quere, R., and Durbeej, M. (2011) Proteasome inhibition improves the muscle of laminin -2 chain-deficient mice. Hum. Mol. Genet. 20, 541-552
26. Vizcaíno, J. A., Deutsch, E. W., Wang, R., Csordas, A., Reisinger, F., Ríos, D., Dianes, J. A., Sun, Z., Farrah, T., Bandeira, N., Binz, P. A., Xenarios, I., Eisenacher, M., Mayer, G., Gatto, L., Campos, A., Chalkley, R. J., Kraus, H. J., Albar, J. P., Martinez-Bartolomé, S., Apweiler, R., Omenn, G. S., Martens, L., Jones, A. R., and Hermjakob, H. (2014) Proteome-Xchange provides globally co-ordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226
27. Karp, N. A., McCormick, P. S., Russell, M. R., and Lilley, K. S. (2007) Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis. Mol. Cell. Proteomics 6, 1354-1364
28. Storey, J. D., and Tibshirani, R. (2003) Statistical significance for genome wide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445
29. Levin, Y. (2011) The role of statistical power analysis in quantitative proteomics. Proteomics 11, 2565-2567
30. Gawlik, K., Miyagoe-Suzuki, Y., Ekblom, P., Takeda, S., and Durbeej, M. (2004) Laminin -1 chain reduces muscular dystrophy in laminin -2 chain deficient mice. Hum. Mol. Genet. 13, 1775-1784
31. Kline, K. G., and Wu, C. C. (2009) MudPIT analysis: application to human heart tissue. Methods Mol. Biol. 528, 281-293
32. Martins de Souza, D., Oliveira, B. M., Castro-Dias, E., Winck, F. V., Horiuchi, R. S., Baldasso, P. A., Caetano, H. T., Pires, N. K., Marangoni, S., and Novello, J. C. (2008) The untiring search for the most complete proteome representation: reviewing the methods. Brief Funct. Genomic. Proteomic. 7, 312-321
33. Miyagoe, Y., Hanaoka, K., Nonaka, I., Hayasaka, M., Nabeshima, Y., Arahata, K., Nabeshima, Y., and Takeda, S. (1997) Laminin -2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett. 415, 33-39
34. Häger, M., Bigotti, M. G., Meszaros, R., Carmignac, V., Holmberg, J., Allamand, V., Åkerlund, M., Kalamajski, S., Brancaccio, A., Mayer, U., and Durbeej, M. (2008) Cib2 binds integrin -7B-1D and is reduced in laminin -2 chain-deficient muscular dystrophy. J. Biol. Chem. 283, 24760-247695
35. Deconinck, N., and Dan, B. (2007) Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr. Neurol. 26, 1-7
36. Vandebrouck, C., Martin, D., Colson-Van Schoor, M., Debaix, H., and Gailly, P. (2002) Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J. Cell Biol. 158, 1089-1096
37. Millay, D. P., Sargent, M. A., Osinska, H., Baines, C. P., Barton, E. R., Vuagniaux, G., Sweeney, H. L., Robbins, J., and Molkentin, J. D. (2008) Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med. 14, 442-447
38. Millay, D. P., Goonasekera, S. A., Sargent, M. A., Maillet, M., Aronow, B. J., and Molkentin, J. D. (2009) Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 106, 19023-19028
39. Culligan, K. G., and Ohlendieck, K. (2002) Abnormal calcium handling in muscular dystrophy. Basic Appl. Myol. 12, 147-157
40. Straub, V., Rafael, J. A., Chamberlain, J. S., and Campbell, K. P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375-385
41. Gawlik, K. I., Åkerlund, M., Carmignac, V., Elamaa, H., and Durbeej, M. (2010) Distinct roles for laminin globular domains in laminin -1 chain mediated rescue of murine laminin -2 chain deficiency. PLoS One 5, e11549
42. Rescher, U., and Gereke, V. (2004) Annexins-unique membrane binding proteins with diverse functions. J. Cell Sci. 117, 2631-2639
43. Probst-Cousinm, S., Berghoff, C., Neundörfer, B., and Heuss, D. (2004) Annexin expression in inflammatory myopathies. Muscle Nerve 30, 102-110
44. Jeudi, S., Wardrop, K. E., Alessi, A., and Dominov, J. A. (2011) Bcl-2 inhibits the innate immune response during early pathogenesis of murine congenital muscular dystrophy. PLoS One 6, e22369
45. Taniguchi, M., Kurahashi, H., Noguchi, S., Sese, J., Okinaga, T., Tsukahara, T., Guicheney, P., Ozono, K., Nishino, I., Morishita, S., and Toda, T. (2006) Expression profiling from Fukuyama-type congenital muscular dystrophy and laminin-2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease? Biochem. Biophys. Res. Commun. 342, 489-502
46. Kuang, W., Xu, H., Vachon, P. H., and Engvall, E. (1998) Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J. Clin. Invest. 102, 844-852
47. Meinen, S., Barzaghi, P., Lin, S., Lochmuller, H., and Rüegg M. A. (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-2-deficient muscular dystrophy at all disease stages. J. Cell Biol. 176, 979-993
48. Doe, J. A., Wuebbles, R. D., Allred, E. T., Rooney, J. E., Elorza, M., and Burkin, D. J. (2011) Transgenic overexpression of the -7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. J. Cell Sci. 124, 2287-2297
49. Girgenrath, M., Dominov, J. A., Kostek, C. A., and Miller, J. B. (2004) Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J. Clin. Invest. 114, 1635-1639
50. Erb, M., Meinen, S., Barzaghi, P., Sumanovski, L. T., Courdier-Fruh, I., Rüegg, M. A., and Meier, T. (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-2 deficiency. J. Pharmacol. Exp. Ther. 331, 787-795
51. Kumar, A., Yamauchi, J., Girgenrath, T., and Girgenrath, M. (2011) Musclespecific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Hum. Mol. Genet. 20, 2333-2343
52. Carmignac, V., Svensson, M., Körner, Z., Elowsson, L., Matsumura, C., Gawlik, K., Allamand, V., and Durbeej, M. (2011) Autophagy is increased in laminin -2 chain-deficient muscle and inhibition improves muscle morphology in a mouse model of MDC1A. Hum. Mol. Genet. 20, 4891-4902
53. Rooney, J. E., Knapp, J. R., Hodges, B. L., Wuebbles, R. D., and Burkin, D. J. (2011) Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am. J. Pathol. 180, 1593-1602
54. Elbaz, M., Yanay, N., Aga-Mizrachi, S., Brunschwig, Z., Kassis, I., Ettinger, K., Barak, V., and Nevo, Y. (2012) Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy2J/dy2J mouse. Ann. Neurol. 71, 699-708
55. Meinen, S., Lin, S., and Rüegg, M. A. (2012) Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-2-deficient congenital muscular dystrophy (MDC1A). Skelet. Muscle 2, 18
56. Turk, R., Sterrenburg, E., van der Wees, C. G., de Meijer, E. J., de Menezes, R. X., Groh, S., Campbell, K. P., Noguchi, S., van Ommen, G. J., den Dunnen, J. T., and 't Hoen, P. A. (2006) Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J. 20, 127-129
57. Chen, Y. W., Zhao, P., Borup, R., and Hoffman, E. P. (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell Biol. 151, 1321-1336
58. Chinet, A. E., Even, P. C., and Decrouy, A. (1994) Dystrophin-dependent efficiency of metabolic pathways in mouse skeletal muscles. Experientia 59, 602-605
59. Even, P. C., Decrouy, A., and Chinet, A. (1994) Defective regulation of energy metabolism in the mdx-mouse skeletal muscles. Biochem. J. 304, 649-654
60. Groh, S., Zong, H., Goddeeris, M. M., Lebakken, C. S., Venzke, D., Pessin, J. E., and Campbell, K. P. (2009) Sarcoglycan complex: implications for metabolic defects in muscular dystrophies. J. Biol. Chem. 284, 19178-19182
61. Onopiuk, M., Brutkowski, W., Wierzbicka, K., Wojciechowska, S., Szczepanowska, J., Fronk, J., Lochmuller, H., Gorecki, D. C., and Zablocki, K. (2009) Biochem. Biophys. Res. Commun. 386, 463-466
62. Le Borgne, F., Guyot, S., Logerot, M., Beney, L., Gervais, P., and Demarquoy, J. (2012) Exploration of lipid metabolism in relation with plasma membrane properties of Duchenne muscular dystrophy cells: influence of L-carnitine. PLoS One 7, e49346
63. Matsumura, C. Y., Pertille, A., Albuquerge, T. C., Santo Neto, H., and Marques, M. J. (2009) Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability. Muscle Nerve 39, 167-176
64. Jørgensen, L. H., Blain, A., Greally, E., Lavala, S. H., Blamire, A. M., Davison, B. J., Brinkmeier, H., MacGowan, G. A., Schrøder, H. D., Bushby, K., Straub, V., and Lochmüller, H. (2011) Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle. Am. J. Pathol. 178, 273-283
65. Goonasekera, S. A., Lam, C. K., Millay, D. P., Sargent, M. A., Hajjar, R. J., Kranias, E. G., and Molkentin, J. D. (2011) Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J. Clin. Invest. 121, 1044-1052
66. Horiuchi, K., Amizuka, N., Takeshita, S., Takamatsu, H., Katsuura, M., Ozawa, H., Toyama, Y., Bonewald, L. F., and Kudo, A. (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor -. J. Bone Miner. Res. 14, 1239-1249
67. Lorts, A., Schwanekamp, J. A., Baudino, T. A., McNally, E. M., and Molkentin, J. D. (2012) Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor- pathway. Proc. Natl. Acad. Sci. U.S.A. 109, 10978-10983
68. Ting, L., Rad, R., Gygi, S. P., and Haas, W. (2011) MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat. Methods 8, 937-940
69. Christoforou, A., and Lilley, K. S. (2011) Taming the isobaric tagging elephant in the rooms in quantitative proteomics. Nat. Methods 8, 911-913